Vaccines
-
How Personalized mRNA Vaccines Target Neoantigens to Beat Melanoma
Discover how custom mRNA cancer vaccines train the immune system against tumor neoantigens to prevent melanoma recurrence compared to standard adjuvant therapy.
-
Uganda Trial: One-Fifth Yellow Fever Dose Works in Children
KAMPALA, September 13 — A clinical trial in Uganda has found that a one-fifth dose of yellow fever vaccine protected children under…
-
Ebola Outbreak in DR Congo Surpasses Containment, WHO Alerts
Mbandaka, August 20 — The Democratic Republic of the Congo faces a resurgent Ebola outbreak that health authorities are struggling to contain,…
-
Measles resurgence fuels global comeback amid declining vaccination rates
GENEVA, July 21 — In the corridors of global health agencies, a familiar concern has resurfaced. Measles, a disease whose very name…
-
US Vaccine Hesitancy Fuels Preventable Disease Outbreaks, Threatens
MANILA, July 21 — Vaccine hesitancy — a delay in accepting or refusing vaccines despite their availability and proven effectiveness — has…
-
Vaccines Train Immune System: A Century of Disease Prevention
ASTANA, July 14 — The global vaccine market, a sector that directly shapes public health outcomes from Central Asia to the Americas,…
-
Global Vaccination Impact: 2 to 3 Million Deaths Prevented Annually
WASHINGTON, July 14 — Vaccines remain one of the most powerful tools in public health, preventing an estimated 2 to 3 million…
-
Innate vs. Adaptive Immunity: Two-Layered Defense System
MANILA, July 14 — For families across Asia, the idea of being protected from a disease long after recovery is something many…
-
Vaccine Development Timeline: From 1796 to mRNA in 2020
ROME, July 14 — For families, the story of vaccines is not a dry list of dates and laboratories. It is the…
-
Jonas Salk’s 1955 Polio Vaccine Reduced U.S. Cases By 96 Percent
WASHINGTON, July 14 — The geopolitical chessboard of global health has few moves as decisive as the one Jonas Salk made in…
-
Preclinical Vaccine Neutralizes Fentanyl and 10 Analogs
HOUSTON, July 13 — A fentanyl vaccine candidate has moved one step closer to human testing, with preclinical results showing it blocked…
-
Vaccinated mice show promise in blocking fentanyl’s deadly effects
WASHINGTON — Inside a laboratory, a small group of mice is changing how researchers think about the opioid crisis. These animals, immunized…
-
Scripps Chemist Develops Vaccine To Train Immune System Against Fentanyl
LA JOLLA — Dr. Kim D. Janda is working on a vaccine that could change how the country fights the fentanyl crisis.…
-
Dr. Christopher Fox, HDT Bio President, Built LION Platform
SEATTLE, July 13 — The global chessboard of infectious disease is seeing a strategic pivot. As the world recalibrates its approach to…
-
Vaccine blocks fentanyl from brain, clears animal trials
ISLAMABAD, July 13 — A vaccine candidate designed to block fentanyl from reaching the brain has completed preclinical studies in animals, with…
-
Clinical Timeline: Human Trials Expected to Begin Within Two Years
WASHINGTON, July 13 — A vaccine candidate designed to prevent fentanyl overdoses is moving toward human clinical trials, offering a potential new…
-
University of Washington Vaccine Candidate Published in Nature Communications
SEATTLE — A new vaccine candidate developed at the University of Washington School of Medicine has been published in Nature Communications ,…
-
University of Houston Fentanyl Vaccine Targets Drug’s Chemical Backbone
HOUSTON, July 13 — A novel vaccine candidate developed at the University of Houston is targeting the chemical backbone of fentanyl and…
-
“UH Researchers Develop Fentanyl Vaccine to Combat Rising Overdoses”
HOUSTON, July 13 — A team of researchers at the University of Houston is developing a vaccine candidate designed to target fentanyl,…
-
Next Steps From Preclinical to Human Trials Expected to Take Years
WASHINGTON, July 13 — The figure that matters for a potential breakthrough in the opioid crisis is 10 to 15 years. That…
-
Vaccines and Immunotherapy Harness Immune System to Fight Disease
ISLAMABAD, July 10 — Vaccines and immunotherapies are transforming how medicine approaches both prevention and treatment, with a growing body of evidence…
-
From Jenner’s smallpox vaccine to modern immunotherapy
MANILA, July 10 — The story of how humanity learned to fight disease is a long one, and for families across Asia,…
-
Katalin Karikó’s mRNA research wins 2023 Nobel Prize
LONDON, July 10 — The detail that matters in the story of Katalin Karikó is not the Nobel Prize, nor the 95%…
-
Decades of mRNA Research Led to Fastest Vaccines by 2020
ROME, July 10 — The story of messenger RNA vaccines begins not in a pandemic, but in a laboratory mouse. In 1990,…
Most read
-
Minnesota Makes Personal Finance Course Mandatory for High School Graduation
-
UK Households With £10,000 Risk Losing £300 To Low Interest Rates
-
Selangor International Care Expo in Kuala Lumpur 2026
-
Asian & Oceanian Epilepsy Congress 2026 in Kuala Lumpur
-
Baby & Beyond Maternity Expo in Kuala Lumpur 2026
-
Why Long COVID Raises Hypertension Risk and How to Monitor Your Blood Pressure
-
Amgen and AstraZeneca Combination Therapy Shows Unprecedented Survival Gains in Lung Cancer
-
Moderna’s mRNA Platform Enables Rapid Personalized Cancer Vaccines
-
Evaluating Skyrizi’s Efficacy and Market Position in Crohn’s Disease Care
-
How Personalized mRNA Vaccines Target Neoantigens to Beat Melanoma
-
Nationwide Rate Boost: How Rising Cash ISA Yields Beat Inflation Without Long-Term Lock-Ins
-
Estate Taxes Hit Retirees Selling High-Value Art: Navigating Double Taxation Risks
-
How Revolving Credit Card Balances Drive Industry Profits and Stifle Budgets
-
Why Medicare Documentation Rules Drive Denied Claims for Diabetic Shoes
-
Suze Orman: Why Medical Costs Demand an 8-Month Emergency Fund
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Dennis Lo Pioneers Liquid Biopsy for Cancer and Prenatal Testing
-
New Research Highlights Rising Internet Addiction Debate
-
Study Suggests Drinking Water With Meals May Lead To Overeating
-
Real-World Oncotype DX Adoption: Rates and Key Challenges
-
Energy Drinks: Youth Marketing, Caffeine Risks Under Scrutiny
-
ADHD Dopamine Dysfunction Disrupts Sleep-Wake Cycles, Study Finds
























